Search:

Login | Subscribe

Home > Companies > GeneMedix plc

Price	Market	Sector	Market Cap
1.75p (0.00p) 0.00%	AIM	Medicine and Biotech Research	£2.73m

Add to company folder | Print

Related Companies

AGY	10.00p	0.00%
APH	4.62p	0.00%
CBF	2.00p	-11.11%
CRX	2.75p	0.00%
EVC	25.75p	0.00%
FUL	3.12p	0.00%
FUM	28.25p	-2.59%
GWP	30.00p	0.00%
HML	0.42p	0.00%
MMG	7.25p	0.00%
MPM	14.25p	0.00%
OMH	3.50p	0.00%
PLE	16.50p	0.00%
PRM	20.50p	-8.89%
PRX	145.00p	5.46%
RNSM	7.75p	0.00%
RCG	35.00p	-6.67%
RGT	6.50p	0.00%

Commentary

Biopharmaceutical company specialising in the development and manufacture of biosimilar pharmaceuticals

Recent Articles

Newcomer - GeneMedix	16/02/2007
GeneMedix loses interim £2.7m	26/08/2005
GeneMedix	16/10/2001
GeneMedix	16/02/2001
Ambitious plans afoot at Gene Medix	23/11/2000

Recent Announcements

Change of Company Name	16/10/2008
Death of Non-Exec Director	08/10/2008
Final Results	09/09/2008
Directorate Change	28/01/2008
Directorate Change	12/12/2007
Interim Results	30/11/2007
AGM resolutions passed	19/09/2007
Change of Adviser	18/07/2007
Restoration - GeneMedix Plc	18/07/2007
Temporary Suspension	02/07/2007
More

Articles from the Sector

Stroke hope at ReNeuron	28/11/2008
Futura Medical	28/11/2008
Option deal boosts ImmuPharma	25/11/2008
Digital imager targets AIM	24/11/2008
Vectura loses interim £11.7m	24/11/2008
GW trims loss	19/11/2008
Asterand	18/11/2008
EU trial cheers Plethora	07/11/2008
IS Pharma	05/11/2008
Animalcare nurturing high-margin growth	03/11/2008
More

Financial History

Financial Year End	30/11/2003	30/11/2004	30/11/2005	31/03/2007	31/03/2008
Currency	GBP	GBP	GBP	GBP	GBP
Turnover	0.02	0.00	0.00	0.00	0.00
Operating Profit	-6.94	-6.72	-5.63	-7.50	-5.50
Pretax Profit	-7.23	-7.10	-5.60	-5.51	-5.24
Earnings After Tax	-7.23	-5.81	-5.14	-5.17	-5.24
Profit Available For Dividend	0.00	0.00	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00	0.00	0.00
Retained Profit	-7.07	0.00	-5.14	0.00	0.00
Shareholders Funds	5.50	2.58	1.03	11.64	6.45
Net Current Assets	0.44	-0.06	0.27	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	0.00	0.00	-8.11	-3.40
Adj Earnings Per Share	0.00	0.00	0.00	-8.11	-3.40
Dividend Per Share	0.00	0.00	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address	Business & Technology Park, Srah, Tullamore, CB8 7XN
Telephone	+353 5793 23572
Fax	+353 5793 23592
Executives
Chairman	Ramesh Mashelkar (0.00% holding)
Chief Executive	Vinay Ranade (0.00% holding)
Finance Director	as above (0.00% holding)
Director	Gerhard Klement (0.00% holding)
Main Shareholders
	Reliance Life Sciences: 75% Kim Tan: 9.4%
Advisers
Nominated Adviser	Deloitte
Nominated Broker	The Share Centre
Solicitors	CMS Cameron McKenna
Auditors	PricewaterhouseCoopers
Registrar	n/a

Commentary
Biopharmaceutical company specialising in the development and manufacture of biosimilar pharmaceuticals
Company Data
Code	GMX
Sedol	GB00B1MM99
Shares In Issue	155.718 m
Indices
Entry on AIM	16/02/2007
Interim Results	Nov
Final Results	Sep
Year End	Mar
Accounts Due	n/a
Int div payment	n/a
Fin div payment	n/a
Int net div per share	nil
Fin net div per share	nil
Probable CGT relief	Yes